Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient?s body.
This report aims to provide a comprehensive presentation of the global market for Chronic Phase Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Phase Marker. This report contains market size and forecasts of Chronic Phase Marker in global, including the following market information:
Global Chronic Phase Marker Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Phase Marker market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tumor Markers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Phase Marker include Nordic BioSite, DiaSorin, Roche, Bristol-Myers Squibb, Hologic, QIAGEN, Philips, Johnson & Johnson and Lifesign, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Phase Marker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Phase Marker Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Chronic Phase Marker Market Segment Percentages, by Type, 2022 (%)
Tumor Markers
Cardiac Markers
Thyroid Markers
Others
Global Chronic Phase Marker Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Chronic Phase Marker Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Laboratories
Global Chronic Phase Marker Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Chronic Phase Marker Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Phase Marker revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Phase Marker revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Phase Marker, market overview.
Chapter 2: Global Chronic Phase Marker market size in revenue.
Chapter 3: Detailed analysis of Chronic Phase Marker company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Phase Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Phase Marker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Phase Marker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Phase Marker Overall Market Size
2.1 Global Chronic Phase Marker Market Size: 2022 VS 2030
2.2 Global Chronic Phase Marker Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Phase Marker Players in Global Market
3.2 Top Global Chronic Phase Marker Companies Ranked by Revenue
3.3 Global Chronic Phase Marker Revenue by Companies
3.4 Top 3 and Top 5 Chronic Phase Marker Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chronic Phase Marker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Phase Marker Players in Global Market
3.6.1 List of Global Tier 1 Chronic Phase Marker Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Phase Marker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Phase Marker Market Size Markets, 2022 & 2030
4.1.2 Tumor Markers
4.1.3 Cardiac Markers
4.1.4 Thyroid Markers
4.1.5 Others
4.2 By Type - Global Chronic Phase Marker Revenue & Forecasts
4.2.1 By Type - Global Chronic Phase Marker Revenue, 2018-2023
4.2.2 By Type - Global Chronic Phase Marker Revenue, 2024-2030
4.2.3 By Type - Global Chronic Phase Marker Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Phase Marker Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Laboratories
5.2 By Application - Global Chronic Phase Marker Revenue & Forecasts
5.2.1 By Application - Global Chronic Phase Marker Revenue, 2018-2023
5.2.2 By Application - Global Chronic Phase Marker Revenue, 2024-2030
5.2.3 By Application - Global Chronic Phase Marker Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Chronic Phase Marker Market Size, 2022 & 2030
6.2 By Region - Global Chronic Phase Marker Revenue & Forecasts
6.2.1 By Region - Global Chronic Phase Marker Revenue, 2018-2023
6.2.2 By Region - Global Chronic Phase Marker Revenue, 2024-2030
6.2.3 By Region - Global Chronic Phase Marker Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Chronic Phase Marker Revenue, 2018-2030
6.3.2 US Chronic Phase Marker Market Size, 2018-2030
6.3.3 Canada Chronic Phase Marker Market Size, 2018-2030
6.3.4 Mexico Chronic Phase Marker Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Chronic Phase Marker Revenue, 2018-2030
6.4.2 Germany Chronic Phase Marker Market Size, 2018-2030
6.4.3 France Chronic Phase Marker Market Size, 2018-2030
6.4.4 U.K. Chronic Phase Marker Market Size, 2018-2030
6.4.5 Italy Chronic Phase Marker Market Size, 2018-2030
6.4.6 Russia Chronic Phase Marker Market Size, 2018-2030
6.4.7 Nordic Countries Chronic Phase Marker Market Size, 2018-2030
6.4.8 Benelux Chronic Phase Marker Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Chronic Phase Marker Revenue, 2018-2030
6.5.2 China Chronic Phase Marker Market Size, 2018-2030
6.5.3 Japan Chronic Phase Marker Market Size, 2018-2030
6.5.4 South Korea Chronic Phase Marker Market Size, 2018-2030
6.5.5 Southeast Asia Chronic Phase Marker Market Size, 2018-2030
6.5.6 India Chronic Phase Marker Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Chronic Phase Marker Revenue, 2018-2030
6.6.2 Brazil Chronic Phase Marker Market Size, 2018-2030
6.6.3 Argentina Chronic Phase Marker Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Phase Marker Revenue, 2018-2030
6.7.2 Turkey Chronic Phase Marker Market Size, 2018-2030
6.7.3 Israel Chronic Phase Marker Market Size, 2018-2030
6.7.4 Saudi Arabia Chronic Phase Marker Market Size, 2018-2030
6.7.5 UAE Chronic Phase Marker Market Size, 2018-2030
7 Chronic Phase Marker Companies Profiles
7.1 Nordic BioSite
7.1.1 Nordic BioSite Company Summary
7.1.2 Nordic BioSite Business Overview
7.1.3 Nordic BioSite Chronic Phase Marker Major Product Offerings
7.1.4 Nordic BioSite Chronic Phase Marker Revenue in Global Market (2018-2023)
7.1.5 Nordic BioSite Key News & Latest Developments
7.2 DiaSorin
7.2.1 DiaSorin Company Summary
7.2.2 DiaSorin Business Overview
7.2.3 DiaSorin Chronic Phase Marker Major Product Offerings
7.2.4 DiaSorin Chronic Phase Marker Revenue in Global Market (2018-2023)
7.2.5 DiaSorin Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Chronic Phase Marker Major Product Offerings
7.3.4 Roche Chronic Phase Marker Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Chronic Phase Marker Major Product Offerings
7.4.4 Bristol-Myers Squibb Chronic Phase Marker Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Hologic
7.5.1 Hologic Company Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Chronic Phase Marker Major Product Offerings
7.5.4 Hologic Chronic Phase Marker Revenue in Global Market (2018-2023)
7.5.5 Hologic Key News & Latest Developments
7.6 QIAGEN
7.6.1 QIAGEN Company Summary
7.6.2 QIAGEN Business Overview
7.6.3 QIAGEN Chronic Phase Marker Major Product Offerings
7.6.4 QIAGEN Chronic Phase Marker Revenue in Global Market (2018-2023)
7.6.5 QIAGEN Key News & Latest Developments
7.7 Philips
7.7.1 Philips Company Summary
7.7.2 Philips Business Overview
7.7.3 Philips Chronic Phase Marker Major Product Offerings
7.7.4 Philips Chronic Phase Marker Revenue in Global Market (2018-2023)
7.7.5 Philips Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Chronic Phase Marker Major Product Offerings
7.8.4 Johnson & Johnson Chronic Phase Marker Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Lifesign
7.9.1 Lifesign Company Summary
7.9.2 Lifesign Business Overview
7.9.3 Lifesign Chronic Phase Marker Major Product Offerings
7.9.4 Lifesign Chronic Phase Marker Revenue in Global Market (2018-2023)
7.9.5 Lifesign Key News & Latest Developments
7.10 Natus
7.10.1 Natus Company Summary
7.10.2 Natus Business Overview
7.10.3 Natus Chronic Phase Marker Major Product Offerings
7.10.4 Natus Chronic Phase Marker Revenue in Global Market (2018-2023)
7.10.5 Natus Key News & Latest Developments
7.11 BrainScope
7.11.1 BrainScope Company Summary
7.11.2 BrainScope Business Overview
7.11.3 BrainScope Chronic Phase Marker Major Product Offerings
7.11.4 BrainScope Chronic Phase Marker Revenue in Global Market (2018-2023)
7.11.5 BrainScope Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chronic Phase Marker Market Opportunities & Trends in Global Market
Table 2. Chronic Phase Marker Market Drivers in Global Market
Table 3. Chronic Phase Marker Market Restraints in Global Market
Table 4. Key Players of Chronic Phase Marker in Global Market
Table 5. Top Chronic Phase Marker Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chronic Phase Marker Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chronic Phase Marker Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chronic Phase Marker Product Type
Table 9. List of Global Tier 1 Chronic Phase Marker Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Phase Marker Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Phase Marker Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Chronic Phase Marker Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chronic Phase Marker Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Chronic Phase Marker Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Chronic Phase Marker Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chronic Phase Marker Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Chronic Phase Marker Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Chronic Phase Marker Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chronic Phase Marker Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Chronic Phase Marker Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chronic Phase Marker Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Chronic Phase Marker Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chronic Phase Marker Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Chronic Phase Marker Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chronic Phase Marker Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Chronic Phase Marker Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chronic Phase Marker Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Chronic Phase Marker Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chronic Phase Marker Revenue, (US$, Mn), 2024-2030
Table 30. Nordic BioSite Company Summary
Table 31. Nordic BioSite Chronic Phase Marker Product Offerings
Table 32. Nordic BioSite Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 33. Nordic BioSite Key News & Latest Developments
Table 34. DiaSorin Company Summary
Table 35. DiaSorin Chronic Phase Marker Product Offerings
Table 36. DiaSorin Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 37. DiaSorin Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Chronic Phase Marker Product Offerings
Table 40. Roche Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Chronic Phase Marker Product Offerings
Table 44. Bristol-Myers Squibb Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Hologic Company Summary
Table 47. Hologic Chronic Phase Marker Product Offerings
Table 48. Hologic Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 49. Hologic Key News & Latest Developments
Table 50. QIAGEN Company Summary
Table 51. QIAGEN Chronic Phase Marker Product Offerings
Table 52. QIAGEN Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 53. QIAGEN Key News & Latest Developments
Table 54. Philips Company Summary
Table 55. Philips Chronic Phase Marker Product Offerings
Table 56. Philips Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 57. Philips Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Chronic Phase Marker Product Offerings
Table 60. Johnson & Johnson Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Lifesign Company Summary
Table 63. Lifesign Chronic Phase Marker Product Offerings
Table 64. Lifesign Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 65. Lifesign Key News & Latest Developments
Table 66. Natus Company Summary
Table 67. Natus Chronic Phase Marker Product Offerings
Table 68. Natus Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 69. Natus Key News & Latest Developments
Table 70. BrainScope Company Summary
Table 71. BrainScope Chronic Phase Marker Product Offerings
Table 72. BrainScope Chronic Phase Marker Revenue (US$, Mn) & (2018-2023)
Table 73. BrainScope Key News & Latest Developments
List of Figures
Figure 1. Chronic Phase Marker Segment by Type in 2022
Figure 2. Chronic Phase Marker Segment by Application in 2022
Figure 3. Global Chronic Phase Marker Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Phase Marker Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chronic Phase Marker Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Phase Marker Revenue in 2022
Figure 8. By Type - Global Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 9. By Application - Global Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 10. By Type - Global Chronic Phase Marker Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 12. By Application - Global Chronic Phase Marker Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 14. By Region - Global Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 15. By Country - North America Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 16. US Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 20. Germany Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 21. France Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 28. China Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 32. India Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 34. Brazil Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Chronic Phase Marker Revenue Market Share, 2018-2030
Figure 37. Turkey Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Chronic Phase Marker Revenue, (US$, Mn), 2018-2030
Figure 41. Nordic BioSite Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. DiaSorin Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hologic Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. QIAGEN Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Philips Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lifesign Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Natus Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BrainScope Chronic Phase Marker Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
